FDA Inspection 1040735 — SEAGEN INC.
The FDA completed an inspection of SEAGEN INC. on January 5, 2018 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 5, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bothell, WA (United States)